A
$ Value
$0
Shares
72,750
Price
$0
Filed
Jun 26
Insider
Name
Roberts Eric W
Title
CHIEF BUSINESS OFFICER
CIK
0001576244
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2025-06-24
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
72,750
Footnotes
The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025. | Immediately exercisable.
Filing Info
Roberts Eric W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-18 | CALC | ▲ | $8K |
| 2025-09-15 | CALC | ▲ | $9K |
| 2025-09-12 | CALC | ▲ | $16K |
| 2025-09-09 | CALC | ▲ | $7K |
| 2025-08-29 | CALC | ▲ | $2K |
| 2025-08-28 | CALC | ▲ | $26K ★ |
| 2025-08-21 | CALC | ▲ | $10K |
| 2025-08-20 | CALC | ▲ | $5K |
| 2025-08-20 | CALC | M | $23K |
| 2025-08-20 | CALC | M | $23K |
Other Insiders at CALC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
|
— | — | 2025-04-05 |
|
Roberts Eric W
CHIEF BUSINESS OFFICER
|
— | — | 2025-04-05 |
|
Bardin Stephen
Chief Financial Officer
|
— | — | 2025-04-05 |
|
Dunn Michael J.
President and COO
|
— | — | 2025-04-05 |
|
Hebbar Sudarshan
Chief Medical Officer
|
— | — | 2025-04-05 |
|
Stauderman Kenneth A.
Chief Scientific Officer
|
— | — | 2025-04-05 |